During the past decade, Clinical Research of Philadelphia, LLC conducted 39 clinical trials. In the 10-year time frame, 39 clinical trials started and 38 clinical trials were completed, i.e. on average, 97.4% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 26 clinical trials were completed. i.e. 185.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinical Research of Philadelphia, LLC" #1 sponsor was "Bayer" with 8 trials, followed by "Pfizer" with 7 trials sponsored, "Ferring Pharmaceuticals" with 5 trials sponsored, "Sebela Women's Health Inc." with 4 trials sponsored and "Allergan" with 4 trials sponsored. Other sponsors include 32 different institutions and companies that sponsored additional 28 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinical Research of Philadelphia, LLC" #1 collaborator was "Health Decisions" with 2 trials as a collaborator, "Synteract, Inc." with 2 trials as a collaborator, "Chemo France" with 1 trials as a collaborator, "Chemo Research" with 1 trials as a collaborator and "ICON plc" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Clinical Research of Philadelphia, LLC" are "Contraception" (10 trials), "Hot Flashes" (6 trials), "Migraine" (5 trials), "Migraine, With or Without Aura" (5 trials) and "Menopause" (4 trials). Many other conditions were trialed in "Clinical Research of Philadelphia, LLC" in a lesser frequency.

Most popular intervention types in "Clinical Research of Philadelphia, LLC" are "Drug" (61 trials), "Device" (3 trials), "Other" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (25 trials), "Rimegepant" (6 trials), "Brisdelle (paroxetine mesylate)" (3 trials), "placebo" (3 trials) and "Colposcopy" (2 trials). Other intervention names were less common.

The vast majority of trials in "Clinical Research of Philadelphia, LLC" are 44 trials for "Female" genders and 20 trials for "All" genders.

Currently, there are NaN active trials in "Clinical Research of Philadelphia, LLC". 1 are not yet recruiting, 7 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 51 completed trials in Clinical Research of Philadelphia, LLC, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Clinical Research of Philadelphia, LLC, 0 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 44 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".